Details for New Drug Application (NDA): 211175
✉ Email this page to a colleague
The generic ingredient in TAZAROTENE is tazarotene. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the tazarotene profile page.
Summary for 211175
Tradename: | TAZAROTENE |
Applicant: | Fougera Pharms Inc |
Ingredient: | tazarotene |
Patents: | 0 |
Profile for product number 001
Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | 0.1% | ||||
Approval Date: | Jan 28, 2019 | TE: | RLD: | No |
Complete Access Available with Subscription